Evidence mapPaperPMID 42033166Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

Temporal Dissociation of Impaired Glucose Tolerance, Adipose Lipid Remodeling and Endothelial Dysfunction in Aorta After HFD Withdrawal.

Krzysztof Czamara, Izabela Czyzynska-Cichon, Anna Bar, Ewa Stanek, Mateusz Wawro, Marta Z Pacia, Zeinep Berkimbayeva, Brygida Marczyk, Elvira Bragado-García, Paloma Palma-Guzman and 2 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Krzysztof CzamaraJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0002-1548-7603
Izabela Czyzynska-CichonJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0002-2684-1057
Anna BarJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0003-0182-6501
Ewa StanekJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0002-4090-6494
Mateusz WawroDepartment of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0002-5964-3639
Marta Z PaciaJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0002-0391-2502
Zeinep BerkimbayevaJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0009-0003-0288-9050
Brygida MarczykJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0001-9104-9528
Elvira Bragado-GarcíaInstituto Pluridisciplinar and Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-9681-3078
Paloma Palma-GuzmanInstituto Pluridisciplinar and Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-4002-3560
Maria S Fernandez-AlfonsoInstituto Pluridisciplinar and Faculty of Pharmacy, Universidad Complutense de Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-9110-8070
Stefan ChlopickiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University in Kraków, Kraków, Poland.ORCID https://orcid.org/0000-0002-2878-3858

Funding

Ministerio de Ciencia e Innovación (MCIN) PID2022-137116OB-I00Narodowe Centrum Nauki (NCN) DEC-2024/53/B/NZ5/03843
6 · The paper itself

Abstract

Glucose intolerance and endothelial dysfunction are metabolic syndrome hallmarks induced by fat load, but their reversibility is not well explored. Here, we characterize the effects of high-fat diet (HFD) withdrawal on systemic glucose tolerance, endothelial function in aorta (thoracic, TA and abdominal, AA), lipid unsaturation of perivascular adipose tissue (PVAT), and mRNA expression profile. We studied the early and late effects of diet change on C57BL/6J mice after 8 weeks of HFD feeding (60 kcal% of fat with 1% of cholesterol) by implementing multimodal functional (in vivo MRI), spectroscopic (Raman spectroscopy), and molecular (RT-qPCR) characterization of aortas and PVATs. As soon as 1 week after HFD withdrawal, glucose tolerance was normalized and accompanied by the reversal of lowered Scd1 gene expression in PVAT and lipid unsaturation index in PVAT of AA, but not of TA. In contrast, impaired acetylcholine-induced vasodilation in aorta, implicating endothelial dysfunction, was only partially reversed 1 week after HFD withdrawal, whereas full restoration occurred after 6 weeks, with slightly earlier recovery in TA compared to AA. Delayed reversal of endothelial dysfunction in aorta after HFD withdrawal was associated with transcriptomic alterations, indicating downregulation of soluble guanylate cyclase signaling, compensatory changes in insulin signaling, and changes in adipokines expression in PVAT, but not in aorta itself. In summary, HFD withdrawal resulted in early restoration of glucose tolerance, and PVAT lipid unsaturation determined by Scd1 that was temporarily dissociated from the reversal of endothelial dysfunction in the aorta possibly due to altered PVAT function featured by impaired guanylate cyclase signaling pathway.

Indexed as

Adipose TissueAortaDiet, High-FatEndothelium, VascularGlucose IntoleranceLipid MetabolismAnimalsMaleMiceMice, Inbred C57BLVasodilationendotheliumglucose toleranceguanylate cyclasehigh‐fat diet reversalobesityperivascular adipose tissuevascular biology

Identifiers

PMID42033166
PMCPMC13109807

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.